These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 14974084)

  • 1. A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity.
    Pitarque M; von Richter O; Rodríguez-Antona C; Wang J; Oscarson M; Ingelman-Sundberg M
    Hum Mutat; 2004 Mar; 23(3):258-66. PubMed ID: 14974084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic NF-Y dependent regulation of human nicotine C-oxidase (CYP2A6).
    von Richter O; Pitarque M; Rodríguez-Antona C; Testa A; Mantovani R; Oscarson M; Ingelman-Sundberg M
    Pharmacogenetics; 2004 Jun; 14(6):369-79. PubMed ID: 15247629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene: impairment of its promoter activity.
    Pitarque M; von Richter O; Oke B; Berkkan H; Oscarson M; Ingelman-Sundberg M
    Biochem Biophys Res Commun; 2001 Jun; 284(2):455-60. PubMed ID: 11394901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3'-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression.
    Wang J; Pitarque M; Ingelman-Sundberg M
    Biochem Biophys Res Commun; 2006 Feb; 340(2):491-7. PubMed ID: 16378601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Cyp2a5 transcription in mouse primary hepatocytes: roles of hepatocyte nuclear factor 4 and nuclear factor I.
    Ulvila J; Arpiainen S; Pelkonen O; Aida K; Sueyoshi T; Negishi M; Hakkola J
    Biochem J; 2004 Aug; 381(Pt 3):887-94. PubMed ID: 15115437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the human CYP2A6 gene.
    Pitarque M; Rodríguez-Antona C; Oscarson M; Ingelman-Sundberg M
    J Pharmacol Exp Ther; 2005 May; 313(2):814-22. PubMed ID: 15671201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro.
    Yoshida R; Nakajima M; Nishimura K; Tokudome S; Kwon JT; Yokoi T
    Clin Pharmacol Ther; 2003 Jul; 74(1):69-76. PubMed ID: 12844137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2A7 pseudogene transcript affects CYP2A6 expression in human liver by acting as a decoy for miR-126.
    Nakano M; Fukushima Y; Yokota S; Fukami T; Takamiya M; Aoki Y; Yokoi T; Nakajima M
    Drug Metab Dispos; 2015 May; 43(5):703-12. PubMed ID: 25710939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.
    Fukami T; Nakajima M; Sakai H; McLeod HL; Yokoi T
    Pharmacogenomics J; 2006; 6(6):401-12. PubMed ID: 16636685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4 alpha to the proximal promoter.
    Onica T; Nichols K; Larin M; Ng L; Maslen A; Dvorak Z; Pascussi JM; Vilarem MJ; Maurel P; Kirby GM
    Mol Pharmacol; 2008 Feb; 73(2):451-60. PubMed ID: 17978169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three haplotypes associated with CYP2A6 phenotypes in Caucasians.
    Haberl M; Anwald B; Klein K; Weil R; Fuss C; Gepdiremen A; Zanger UM; Meyer UA; Wojnowski L
    Pharmacogenet Genomics; 2005 Sep; 15(9):609-24. PubMed ID: 16041240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel human CYP2A6 alleles confound gene deletion analysis.
    Nakajima M; Yoshida R; Fukami T; McLeod HL; Yokoi T
    FEBS Lett; 2004 Jul; 569(1-3):75-81. PubMed ID: 15225612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.
    Oscarson M; McLellan RA; Asp V; Ledesma M; Bernal Ruiz ML; Sinues B; Rautio A; Ingelman-Sundberg M
    Hum Mutat; 2002 Oct; 20(4):275-83. PubMed ID: 12325023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity.
    Wang HH; Chiang AN
    Biochem J; 2004 Jun; 380(Pt 2):455-63. PubMed ID: 14984368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activity.
    Fukami T; Nakajima M; Higashi E; Yamanaka H; Sakai H; McLeod HL; Yokoi T
    Drug Metab Dispos; 2005 Aug; 33(8):1202-10. PubMed ID: 15900015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.
    Oscarson M; McLellan RA; Gullstén H; Agúndez JA; Benítez J; Rautio A; Raunio H; Pelkonen O; Ingelman-Sundberg M
    FEBS Lett; 1999 Oct; 460(2):321-7. PubMed ID: 10544257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.
    Nakajima M; Fukami T; Yamanaka H; Higashi E; Sakai H; Yoshida R; Kwon JT; McLeod HL; Yokoi T
    Clin Pharmacol Ther; 2006 Sep; 80(3):282-97. PubMed ID: 16952495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
    Nakajima M; Kwon JT; Tanaka N; Zenta T; Yamamoto Y; Yamamoto H; Yamazaki H; Yamamoto T; Kuroiwa Y; Yokoi T
    Clin Pharmacol Ther; 2001 Jan; 69(1):72-8. PubMed ID: 11180041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variants of the CRH 5'-flanking region: effects on DNA-protein interactions studied by EMSA in PC12 cells.
    Wagner U; Wahle M; Malysheva O; Wagner U; Häntzschel H; Baerwald C
    Ann N Y Acad Sci; 2006 Jun; 1069():20-33. PubMed ID: 16855132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism.
    Oscarson M
    Drug Metab Dispos; 2001 Feb; 29(2):91-5. PubMed ID: 11159795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.